doi: 10.1016/j.neuint.2019.04.006 190 EngidaworkEGulesserianTSeidlRCairnsNLubecG
Upcoming Giants (in people being less giant) Although there are many other GLP1R agonists in the pipeline across many companies, some of the few standout drugs, in terms of body weight loss efficacy, are worth noting in brief
Given that people and benefit costs are a large portion of business expenses, partnering with finance is a natural step forward
Mohammedi K, Woodward M, Marre M, Colgiuri S, Cooper M, Harrap S, Mancia G, Poulter N, Williams B, Zoungas S, Chalmers J